Abstract
Tumour-invasion like wound healing is characterised by the formation of an extracellular matrix with a high tenascin-C content. The tenascin-C molecule undergoes alternative splicing. Analysis using antibody BC2 indicates that especially the high-molecular tenascin-C (hm tn-C) variants are typically tumour-associated, while distribution in normal tissue is restrictive. This study investigated whether hm tn-C is a suitable indicator of atypical cells with invasive potential in oral brush biopsies. One hundred fifty nine consecutive oral brush biopsies with histopathological diagnoses were analysed for the identification of atypical cells. A standardised haematoxylin and eosin staining plus standardised immunocytochemistry using the monoclonal anti-hm tn-C antibody was performed. The bound hm tn-C antibodies were detected with the streptavidine/alkaline phosphatase technique in the autostainer. Conventional cytology produced four false-positives when identifying atypical cells in brush biopsies of inflammatory/benign hyperproliferative mucosa (specificity 96%), while 10 in 52 carcinomas and three of eight recurrences were not identified (sensitivity 78%). Ten of these 13 non-identified tumours could be marked when adding the hm tn-C assay (increasing specificity to 99%). Combining the two assays also reduced the false-positive outcomes from four to one (increasing sensitivity to 95%). The positive and negative predictive values were 92 and 88% for conventional cytology vs 98 and 97% for the dual assay. (1) A 95%-sensitivity proves hm tn-C assisted conventional cytology to be a suitable means of identifying atypical cells in oral brush biopsies. (2) The positive (98%) and negative (97%) predictive values obtained approximate hm tn-C assisted conventional cytology to laminin-5 (100/97%).
Similar content being viewed by others
References
Adams M, Jones JL, Walker RA, Pringle JH, Bell SC (2002) Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res 62:3289–3297
Berndt A, Borsi L, Hyckel P, Kosmehl H (2001) Fibrillary co-deposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro. J Cancer Res Clin Oncol 127:286–292
Borsi A, Carnemolla B, Nicolo G, Spina B, Tanara G, Zardi L (1992) Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 52:688–692
Burkhardt A (2006) Letter to the editor: very early cytological and DNA-cytometric diagnosis of in situ carcinoma in an immunosuppressed liver transplant recipient. J Oral Pathol Med 35:520–522
Buyukbayram H, Arslan A (2002) Value of tenascin-C content and association with clinicopathological parameters in uterine cervical lesions. Int J Cancer 100(6):719–722
Chiquet-Ehrismann R (2004) Tenascins. Int J Biochem Cell Biol 36:986–990
Driemel O, Hemmer J, Dahse R, Dietmaier W, Tsioutsias T, Buch RS, Reichert TE, Pistner H, Kosmehl H (2005) Laminin-5 identifiziert atypische Zellen in oralen Bürstenbioptaten. Dtsch Zahnarztl Z (Suppl):144
Driemel O, Dahse R, Hakim SG, Tsioutsias T, Pistner H, Reichert TE, Kosmehl H (2006) Laminin-5 immunocytochemistry: a new tool for identifying dysplastic cells in oral brush biopsies. Cytopathology (in press)
Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S, Nakajima Y (2001) Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 92:1419–1426
Franz M, Hansen T, Richter P, Borsi L, Böhmer FD, Hyckel P, Schleier P, Katenkamp D, Zardi L, Kosmehl H, Berndt A (2006) Complex formation of the laminin-5 gamma2 chain and large unspliced tenascin-C in oral squamous cell carcinoma in vitro and in situ: implications for sequential modulation of extracellular matrix in the invasive tumor front. Histochem Cell Biol 126:125–131
Hindermann W, Berndt A, Boris L, Luo X, Hyckel P, Katenkamp D, Kosmehl H (1999) Synthesis and protein distribution of the unspliced large tenascin C-isoform in oral squamous cell carcinoma. J Pathol 189:475–480
Katenkamp K, Berndt A, Hindermann W, Wunderlich H, Haas KM, Borsi L, Zardi L, Kosmehl H (2003) mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma. J Pathol 203:771–779
Maraki D, Becker J, Böcking A (2004) Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med 33:398–404
Maraki D, Hengge UR, Becker J, Böcking A (2006) Very early cytological and DNA-cytometric diagnosis of in situ carcinoma in an immunosuppressed liver transplant recipient. J Oral Pathol Med 35:58–60
Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA (1997) Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer 72:236–240
Poate TW, Buchanan JA, Hodgson TA, Speight PM, Barrett AW, Moles DR, Scully C, Porter SR (2004) An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 40:829–834
Ramos DM, Chen B, Regezi J, Zardi L, Pytela R (1998) Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer 75:680–687
Regezi JA, Ramos DM, Pytela R, Dekker NP, Jordan RC (2002) Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 38:332–336
Remmerbach TW, Weidenbach H, Pomjanski N, Knops K, Mathes S, Hemprich A, Böcking A (2001) Cytologic and DNA-cytometric early diagnosis of oral cancer. Anal Cell Pathol 22:211–221
Remmerbach TW, Weidenbach H, Müller C, Hemprich A, Pomjanski N, Buckstegge B, Böcking A (2003) Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol 25:139–146
Remmerbach TW, Mathes SN, Weidenbach H, Hemprich A, Böcking A (2004) Nichtinvasive Bürstenbiopsie als innovative Methode in der Früherkennung des Mundhöhlenkarzinoms. Mund Kiefer Gesichtschir 8:229–236
Rick GM (2003) Oral brush biopsy: the problem of false positives. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:252
Scheifele C, Schmidt-Westhausen AM, Dietrich T, Reichart PA (2004) The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol 40:824–828
Sciubba JJ (1999) Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. US Collaborative OralCDx Study Group. J Am Dent Assoc 130:1445–1457
Scott IS, Odell E, Chatrath P, Morris LS, Davies RJ, Vowler SL, Laskey RA, Coleman N (2006) A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia. Br J Cancer 94:1170–1175
Svirsky JA, Burns JC, Carpenter WM, Cohen DM, Bhattacharyya I, Fantasia JE, Lederman DA, Lynch DP, Sciubba JJ, Zunt SL (2002) Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent 50:500–503
Tanaka M, Yamazaki T, Araki N, Yoshikawa H, Yoshida T, Sakakura T, Uchida A (2000) Clinical significance of tenascin-C expression in osteosarcoma: tenascin-C promotes distant metastases of osteosarcoma. Int J Mol Med 5:505–510
Tiitta O, Happonen RP, Virtanen I, Luomanen M (1994) Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma. J Oral Pathol Med 23:446–450
Vollmer G, Tan MI, Wunsche W, Frank K (1997) Expression of tenascin-C by human endometrial adenocarcinoma and stroma cells: heterogeneity of splice variants and induction by TGF-beta. Biochem Cell Biol 75:759–769
Wewer de O, Mareel M (2003) The role of tissue stroma in cancer cell invasion. J Pathol 200:429–447
Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C (2003) Tenascin-C expression correlates with prognosis in gastric cancer. Oncology 64:245–250
Acknowledgement
This study was supported by grants from the European Union FP6, LSHC-CT-2003-5032, STROMA; this publication reflects only the authors’ view. The European Commission is not liable for any use that may be made of the information contained.
Author information
Authors and Affiliations
Corresponding author
Additional information
Lecture given at the 56th Congress of the German Society of Oral and Maxillofacial Surgery (DGMKG) in Dresden, Germany, June 7–10, 2006.
Rights and permissions
About this article
Cite this article
Driemel, O., Dahse, R., Berndt, A. et al. High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies. Clin Oral Invest 11, 93–99 (2007). https://doi.org/10.1007/s00784-006-0086-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-006-0086-8